HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Thygeson, P. Search for Related Content PubMed Articles by Thygeson, P.

Mykobakterien und Mykobakterielle Krankheiten

by Gertrud Meibner and Albert Schmiedel. Teil IX "Human and Murine Leprosy," by Saburo Sato, M.D., Leprosy Department and Director of the Research Institute for Tuberculosis and Leprosy, Tohoku University, Sendai (Japan), and Shinji Nishimura, M.D., Chief Professor, Department of Leprosy, The Research Institute for Microbial Diseases, Osaka (Japan). xx + 437 pages, 122 illustrations, 33 in color, and 41 tables. Veb Gustav Fischer Verlag Jena, Jena Villengang. 1967. 113.90 MDN

The authors of this review on human and murine leprosy mention in a foreword to their chapter on human leprosy that despite the numerous contributions to leprosy research that have been made since leprology was first systematized by Danielssen and Boeck in 1948, the cultivation and animal transmission of M. leprae have yet to be achieved. They state that without the cultivation of M. leprae, essential knowledge of the pathogenesis, bacteriology, and immunobiology of the infection is lacking, although brilliant progress has been made in chemotherapy. Improvement, and even disappearance, of the skin eruptions, serious eye lesions, and naso-oral and visceral lesions of the disease is all due to recently developed drugs. In Japanese leprosaria, the number of patients discharged as germ-free is rising every year, and there has been virtual disappearance of pharyngolaryngeal stenosis, which was often fatal in the past.